CD4 + and CD8 § or/j3 § T cells of the T helper cell (Th)2 phenotype produce the cytokines IL-4, IL-5, and IL-13 that promote IgE production and eosinophilic inflammation. IL-4 may play an important role in mediating the differentiation of antigenically naive or/J3 + T cells into Th2 cells. Murine NKI.1 + (CD4 + or CD4-CD8-) e~/[3 + T ceils comprise a J32-microglobulin ([32m)-dependent cell population that rapidly produces IL-4 after cell activation in vitro and in vivo and has been proposed as a source oflL-4 for Th2 cell differentiation. 0t/J3 + CD8 § T cells, most of which require [32m for their development, have also been proposed as positive regulators of allergen-induced Th2 responses. We tested whether [32m-dependent T cells were essential for Th2 cell-mediated allergic reactions by treating wild-type, [32m-deficient (~2m -/ -) , and IL-4-deficient (IL-4 -/ -) mice of the C57BL/6 genetic background with ovalbumin (OVA), using a protocol that induces robust allergic pulmonary disease in wild-type mice. OVAtreated ~2m -/ -mice had circulating levels of total and OVA-specific IgE, pulmonary eosinophilia, and expression of IL-4, IL-5, and IL-13 mtkNA in bronchial lymph node tissue similar to that of OVA-treated wild-type mice. In contrast, these responses in OVA-treated IL-4 -/ -mice were all either undetectable or markedly reduced compared with wild-type mice, confirming that IL-4 was required in this allergic model. These results indicate that the NKI.1 + 0t/J3 + T cell population, as well as other [32m-dependent populations, such as most peripheral od[3 + CD8 + T cells, are dispensable for the Th2 pulmonary response to protein allergens.
Summary
CD4 + and CD8 § or/j3 § T cells of the T helper cell (Th)2 phenotype produce the cytokines IL-4, IL-5, and IL-13 that promote IgE production and eosinophilic inflammation. IL-4 may play an important role in mediating the differentiation of antigenically naive or/J3 + T cells into Th2 cells. Murine NKI.1 + (CD4 + or CD4-CD8-) e~/[3 + T ceils comprise a J32-microglobulin ([32m)-dependent cell population that rapidly produces IL-4 after cell activation in vitro and in vivo and has been proposed as a source oflL-4 for Th2 cell differentiation. 0t/J3 + CD8 § T cells, most of which require [32m for their development, have also been proposed as positive regulators of allergen-induced Th2 responses. We tested whether [32m-dependent T cells were essential for Th2 cell-mediated allergic reactions by treating wild-type, [32m-deficient (~2m -/ -) , and IL-4-deficient (IL-4 -/ -) mice of the C57BL/6 genetic background with ovalbumin (OVA), using a protocol that induces robust allergic pulmonary disease in wild-type mice. OVAtreated ~2m -/ -mice had circulating levels of total and OVA-specific IgE, pulmonary eosinophilia, and expression of IL-4, IL-5, and IL-13 mtkNA in bronchial lymph node tissue similar to that of OVA-treated wild-type mice. In contrast, these responses in OVA-treated IL-4 -/ -mice were all either undetectable or markedly reduced compared with wild-type mice, confirming that IL-4 was required in this allergic model. These results indicate that the NKI.1 + 0t/J3 + T cell population, as well as other [32m-dependent populations, such as most peripheral od[3 + CD8 + T cells, are dispensable for the Th2 pulmonary response to protein allergens.
C
Ytokines produced by T cells are critical regulators of the immune response to pathogens and antigens (1, 2) . CD4 + effector and memory T cells that develop during chronic immune responses tend to express cytokines in mutually exclusive patterns of either the T helper cell (Th)1 (IL-2, IFN-% and TNF- [3) or the Th2 (IL-4, IL-5, and IL-13) phenotypes (1, 2) . Coordinate production of Th2 cytokines is characteristic of responses either to infection with metazoan parasites (2) or to repeated allergen exposure (3). The consequences ofTh2 cytokine expression include increased production of IgE by B cells, an IL-4-dependent effect (4) that, at least in humans, may be augmented by IL-13 (3), as well as inflammation of tissues with eosinophils, a feature that is IL-5 dependent (5-7). Recent studies also suggest that Ix/13 + CD8 + T cells are a potential source o f T h 2 cytokines, such as IL-4 and IL-5 (1, 8) .
Several lines of evidence suggest that IL-4 itself plays a central role in Th2 cell development in vivo. First, mice deficient in IL-4, as a result of disruptive gene targeting, fail to develop IL-5-producing T cells or eosinophilia after challenges with helminths or allergens (9, 10) . Second, treatment of wild-type mice with neutralizing antibodies against IL-4 during primary immunization with protein antigen reduces subsequent antigen-specific production of IL-4 by T cells ex vivo and IL-4 mRNA expression by splenocytes in vivo (11, 12) . Third, studies of the differentiation of antigenically naive T cells in vitro demonstrate that IL-4 promotes Th2-1ike differentiation (13) .
Since IL-4 production by antigenically naive T cells in response to conventional protein antigens or polyclonal activators tends to be low (14) , other cellular sources of IL-4 production have been proposed to promote Th2 differentiation. These include non-T-lineage cells, such as mast cells and basophils (15) , as well as cells of T-lineage, such as the murine NKI.1 + Ix/J3 + T cell population (2, 16) . NKI.1 + c~/[3 + T cells are either CD4 + or CD4-~ED8-by their cell surface phenotype (16) and have been shown to rapidly produce relatively high levels of IL-4 after activation with anti-CD3 monoclonal antibody treatment in vivo (17) . Murine NKI.1 + T cells require [32-microglobulin (132m)-expressing hematopoietic cells for their development in vivo (18) , and the T cell receptors of at least some of these cells recognize antigens bound to CD1, a nonclassic MHC molecule that associates with [32m on the cell surface (16) . Recently , it has been shown that ~2m -/ -mice, which lack the NKI.1 + T-lineage cell population, have an impaired ability to produce IgE in response to polyclonal activation in vivo induced by anti-CD3 mAb or goat antimouse IgD serum (19 
Materials and Methods
Animals. Wild-type C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, ME). ~2m -/ -mice homozygous for targeted disruption of the 132m gene (20) and congenic on the C57BL/6J background were generously provided by Dr. Christopher Wilson (University of Washington). These mice were confirmed to be homozygous for the mutant ~2m allele by staining with immunofluorescent mAbs and FACS | analysis (Becton Dickinson & Co., Inc., Mountain View, CA), which demonstrated the expected decrease in numbers of CD4-CD8 + thymocytes, peripheral CD8 + T cells, and splenic NKI.1 + T cells compared with wild-type mice (19, 20) . IL-4 -/ -mice homozygous for targeted disruption of the IL-4 gene (4) were obtained from Dr. B.J. Fowlkes (National Institutes of Health, Bethesda, MD) and were used after 10 generations of backcrossing onto a C57BL/6J background. All mice were housed in a specific-pathogen-free facility and were 8-12 weeks old.
Experimental Protocol for the Induction of Allergic Pulmonary Disease.
OVA-treated mice received single intraperitoneal injections of 100 ~g of alum-precipitated crystalline OVA (Pierce, Rockford, IL) in 0.2 ml of normal saline on day 1 and day 14, and single intranasal doses of 50 ~g of OVA in 50 ~1 of normal saline on day 14, day 25, day 26, and day 27 as described previously (21) . Sham-sensitized mice were treated identically to OVA-treated mice except that intraperitoneal injections consisted of 0.2 m / o f alum in normal saline, and intranasal doses consisted of 50 ~1 of normal saline. Mice were euthanized on day 28, and plasma, bronchoalveolar lavage fluid, and bronchial lymph node tissue were collected.
Total and OVA-specific IgE ELISA. For determination of total IgE, ELISA plates (ICN, Costa Mesa, CA) were coated with 2 ~g/in/ of rat anti-mouse IgE mAb R35-72 (rat IgG1 isotype; Pharmingen, San Diego, CA) in PBS (pH 7.4) overnight at 4~ Wells were blocked by incubation with PBS and 3% BSA for 2 h. Plasma samples or a purified murine monoclonal IgE standard (clone IgE-2, IgE6; Pharmingen) were diluted in PBS with 3% (wt/vol) BSA and applied for 1.5 h, followed by incubation for 1 h with peroxidase-conjugated rat anti-mouse IgE mAb LO-ME-3 (rat IgG1 isotype; Biosource International, Camarillo, TX) diluted 1:500 in PBS with 50% (vol/vol) normal goat serum (GIBCO BRL, Gaithersburg, MD). Enzyme substrate was added, and well absorbance at 630 nm was determined as described (21) . OVA-specific IgE levels were determined by ELISA using standard methods (21) . A pooled plasma from OVA-immunized BALB/c mice, arbitrarily assigned an OVA-specific IgE titer of 10 U/m/, was included in each assay as a standard.
Bronchoalveolar Lavage. Bronchoalveolar lavage (BAL) fluid was obtained as previously described (21) . The final pooled BAL fluid volume was routinely between 0.9 and 1.1 ml. Cells in the BAL fluid were resuspended, and a small aliquot (50 txl) was counted using a hemocytometer. The remaining fluid was centrifuged at 4~ for 10 min at 200 g, and the cell pellet was resuspended in 0.1 m/ of normal saline containing 10% BSA (Calbiochem, San Diego, CA), applied to microscope slides, and dried. Slides were stained with a solution of 0.05% (wt/vol) aqueous eosin Y (Sigma Chemical Co., St. Louis, MO) and 5% (vol/vol) acetone and counterstained with 0.07% (wt/vol) methylene blue (Allied Chemical Technologies, Inc., Morristown, NJ) in distilled water.
Reverse Transcriptase-PCR of Bronchial Lymph Node Tissue.
Total RNA was isolated from bronchial lymph nodes, and 4 ~g of total RNA per sample was reverse transcribed (21) . PCR was performed for 35 cycles using the temperature and buffer conditions and the primer sequences for murine hypoxanthine phosphoribosyl transferase (HPRT), IL-4, IL-5, and IL-13, as previously described (21, 22) , with the input ofcDNA template either 100 ng (HPRT and IL-4), 200 ng (IL-13), or 500 ng (IL-5). PCR amplification of HPRT and IL-4 transcripts was performed in the presence of 0.075 pg of a competitor plasmid, pQRS (22) , provided by Dr. Richard Locksley (University of California at San Francisco). The competitor plasmid was not included in the IL-13 and IL-5 amplifications, since, in preliminary experiments, this led to a complete loss of detectable IL-5 mRNA-derived or IL-13 mR.NA-derived products. PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining.
Results and Discussion
To determine the importance of [32m-dependent T cells for the development of Th2 responses in vivo, ~2m -/ -, and wild-type C57BL/6 mice were treated with O V A by a protocol that reliably induces OVA-specific IgE, eosinophil accumulation in the lung parenchyma and airway, and increased expression o f T h 2 cytokines in bronchial lymph nodes from mice o f the C57BL/6 strain (21). OVA-treated wildtype mice had > 10-fold higher mean plasma levels of total IgE than sham-sensitized wild-type animals ( Table 1) . As expected, OVA-specific IgE was demonstrable in the plasma of OVA-treated wild-type mice but was undetectable in samples from sham-sensitized wild-type mice ( Table 1) . The plasma levels o f total and OVA-specific IgE in O V Atreated [32m -/ -mice were similar to those of O V Atreated wild-type animals ( Table 1 ), indicating that IgE production was unperturbed.
Our results differ from those of Yoshimoto et al. (19) , who found markedly lower total IgE levels in fl2m -~-mice compared with wild-type C57BL/6 mice 9 d after injection with goat anti-mouse IgD serum. In these experiments, the IgE response of fl2m -/ -mice to anti-lgD injection as well as the N K I . 1 + T cell population was reconstituted to wild-type levels by adoptive transfer of NKI.1 + thymocytes and T cell-depleted splenocytes from wild-type animals (19) . There are at least three possible explanations why the induction of IgE by anti-IgD treatment may require NKI.1 § T cells, whereas immunization with protein antigen does not. First, NKI.1 + T cells might be needed for IgE production in situations in which B cells are the principal APC for T cells, as appears to be the case for anti-IgD treatment (23), but might be dispensable for IgE produced after immunization with conventional protein antigens, a situation in which other APC, particularly dendritic cells, are likely to be important (24) . Second, it is possible that IgE induced after primary immunization with protein antigen may be dependent, at least in part, on NK1.1 + T cells, but that this requirement is abrogated with secondary and additional immunizations. However, we do (Table 2) , with eosinophils comprising the majority of cells (Table 2 and Fig. 1, A and B) . Eosinophils were not observed in sham-sensitized controls of either Table 2 the fl2m -/ -or wild-type groups (Table 1 and Fig. 1 C) . Furthermore, a marked eosinophilic infiltrate in the pulmonary parenchyma was also observed for 132m -/ -and wild-type mice after OVA treatment, but not in sham-sensitized animals (data not shown). Previous work using mice has shown that eosinophil accumulation in the lung and airway in response to OVA treatment requires the Th2 cytokines, IL-4 (10) and IL-5 (5), and is associated with locally increased expression of these cytokines (7) . To determine if the eosinophilic pulmonary inflammation in 132m -/ -and wild-type mice was accompanied by locally increased production of Th2 cytokines by lymphocytes, the amount of cytokine transcripts in the draining bronchial lymph nodes from individual animals was analyzed by reverse transcriptase ( R T ) -PC1L (Fig. 2) . The bronchial lymph nodes of wild-type mice or ~2m -/ -mice treated with OVA ( Fig. 2 A, lanes  4-7 and lanes 10-i3, respectively) had substantially higher levels of transcripts for IL-4, IL-5, and IL-13 compared with those from sham-sensitized controls (lanes 1-3, 8, 9 ). Cytokine m R N A levels in wild-type or B2m -/ -mice were low to undetectable after sham sensitization (Fig. 2  A) . These higher cytokine levels in OVA-treated samples were not attributable to an increased amount of total R N A that was amplifiable by PCR, since the ratio of the R.NAderived and competitor-derived products for H P R T , an abundant housekeeping gene, was similar in all samples. The amount of competitor-derived IL-4 products was also similar in all lanes, indicating that the overall efficiency of P C R amplifications did not vary significantly from sample to sample. The increase in Th2 cytokine abundance in bronchial lymph node tissue suggested that activation of T cells in vivo by allergen occurred normally in ~2m -~-mice. Consistent with this idea, we also found that bronchial lymph node cells from OVA-treated ~2m -/ -or wild-type mice had similar levels of OVA-specific cell proliferation in vitro (data not shown). Together, these data indicate that T cell priming by antigen and expression of Th2-type cytokines occurred normally in ~2m -/ -mice. Our results are consistent with those of Guery et al. (25) , who found that continuous administration of low doses of soluble protein antigens to either wild-type or ~2m -/ -BALB/c mice resulted in Th2-1ike cells that preferentially produced IL-4, rather than IFN-',/, after stimulation with antigen ex vivo. Our results extend these observations by demonstrating that [32m-dependent T cell populations are dispensable in C57BL/6 strain mice for multiple in vivo events characteristic of the allergic response.
To confirm that the IgE production, eosinophilic inflammation, and Th2 cytokine production induced in wildtype and 182m -/-mfice by our OVA-treatment protocol were IL-4 dependent, these responses were analyzed in IL-4 -/-mice. As expected, based on earlier studies (4, 6), OVA-treated IL-4 -/-mice had substantially decreased plasma levels of total and OVA-specific IgE compared with wild-type mice ( Table 1) . The low but detectable amount of total and OVA-specific IgE in IL-4 -/-mice suggests that a portion of IgE production in vivo may be IL-4 independent and is consistent with a report of reduced but detectable levels of total IgE in IL-4 -/-mice infected with Plasmodium (26) . Both BAL fluid cellularity and eosinophilia ( Table 2 and Fig. 1 D) were also markedly decreased in IL-4 -/-mice compared with wild-type animals. Consistent with these findings, which suggested a decreased Th2 immune response in vivo, the levels of IL-5 and IL-13 mRNA in the bronchial lymph nodes of OVAtreated IL-4 -/-mice were dramatically reduced compared with wild-type mice (Fig. 2 B) . These results also indicate that IL-13 expression during allergic reactions in vivo is largely IL-4 dependent, at least in mice.
Our results also suggest that most conventional ot/t3 + CD8 + T cells are dispensable for the Th2 pulmonary responses to OVA. This contrasts with a report (27) in which treatment of thymectomized BALB/c mice with anti-CD8-a mAb prevented OVA-induced eosinophil accumulation and IL-5 mRNA expression by bronchial lymph nodes. Whether these different results reflect the strains used--C57BL/6 versus BALB/c--or the methods employed to eliminate CD8 T cells--genetic versus thymectomy and antibody treatment--remains unresolved. It is possible that anti-CD8-a mAb treatment may eliminate mucosal CD8 + T cells that are required for the allergic pulmonary response, but which are not dependent on 132m for their development, such as CD8 + y/B + T cells (28) . Interestingly, a population of NKI.1 + ~//8 + thymocytes is present in fl2m -/-mice, and like NKI.1 + a/13 + T cells, these ceils rapidly produce IL-4 after polyclonal activation (29) . Therefore, peripheral T cells derived from this NKI.1 + ~//8 + thymocyte population could provide IL-4 for Th2 cell differentiation in ~2m -/-as well as wildtype mice. Whether this cell population expresses CD8-ot in the periphery remains to be determined.
In summary, our results indicate that the Th2 allergic pulmonary response induced by OVA in this model is IL-4 dependent but independent of [32m expression. This argues that 132m-dependent oL/13 + T cells, such as NKI.1 + 0t/~ + T cells, and most class I MHC-restricted a/13 + CD8 T cells are dispensable for a robust Th2 response to protein allergens in vivo. Further studies are required to determine the importance of other cellular sources of IL-4 proposed to influence Th2 differentiation, such as mast cells and basophils, conventional ot/13 + T cells, or ~//8 + T cells (2, 15) .
